Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Methimazole × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Glioblastoma 1

Interventions

Temozolomide 36 Magnetic Resonance Spectroscopy 34 Radiotherapy 19 Specimen Handling 15 Biopsy 11 X-Rays 8 Nivolumab 8 trametinib 7 Blood Specimen Collection 7 pembrolizumab 6 dabrafenib 6 Radiation 6 olaparib 5 fluorodopa F 18 5 Radiotherapy, Intensity-Modulated 5 Phantoms, Imaging 5 Nuclear Medicine Department, Hospital 5 vorasidenib 4 abemaciclib 4 Surgical Procedures, Operative 4 Radiosurgery 4 Lomustine 4 Dianhydrogalactitol 4 Aminolevulinic Acid 4 ulixertinib 3 ribociclib 3 niraparib 3 larotrectinib 3 ivosidenib 3 erdafitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05607407 2026-03-04

Methimazole in Patients With Progressive Glioblastoma

Case Comprehensive Cancer Center

Phase 2 Recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡